Skip to content

Author

Samuel Margolis

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis.

ADCs efficacy in metastatic breast cancer was similar across age groups, though data in early-stage disease were limited, and insufficient age- and treatment-stratified toxicity reporting precludes meaningful safety assessment of ADCs in older adults with breast cancer.

Samuel Margolis, T. R. Kalbasi, Yuliya Zektser et al. · 0 citations
#artificial intelligence Preprint Oct 2026

DrugTargetWorld: A Synthetic Biobank for Training and Benchmarking AI Scientists

Drug target discovery requires distinguishing molecules that causally drive disease from those that are merely associated with it. Training and evaluating AI agents to perform this workflow end-to-end is difficult because real world biobanks lack known causal ground truth and participant-level data is access controlled...

Samuel Margolis, P. Schmiedmayer, A.-J. Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.